Immunic
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $114 | $0 |
Gross Profit | -43 | -43 | 57 | -42 |
EBITDA | -26,777 | -26,825 | -25,596 | -25,684 |
EBIT | -26,820 | -26,868 | -25,631 | -25,726 |
Net Income | -26,820 | -25,473 | -25,175 | -24,368 |
Net Change In Cash | 0 | 0 | 114 | 0 |
Free Cash Flow | -24,645 | -21,823 | -22,966 | -20,853 |
Cash | 55,310 | 14,304 | 35,668 | 59,071 |
Basic Shares | 132,175 | 101,344 | 90,150 | 101,272 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -134 | -111 | -77 | -85 |
EBITDA | -100,373 | -99,112 | -120,330 | -91,580 |
EBIT | -100,507 | -99,223 | -120,407 | -91,665 |
Net Income | -100,507 | -93,612 | -120,407 | -92,794 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 20,875 | -40,459 | ||
Free Cash Flow | -85,030 | -71,162 | -65,256 | -83,300 |
Cash | 35,668 | 46,674 | 106,745 | 86,863 |
Basic Shares | 100,174 | 44,320 | 31,819 | 23,652 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.20 |
2025-03-31 | -$0.25 |
2024-12-31 | -$0.25 |
